167 related articles for article (PubMed ID: 20419161)
1. Oral activated charcoal prevents experimental cerebral malaria in mice and in a randomized controlled clinical trial in man did not interfere with the pharmacokinetics of parenteral artesunate.
de Souza JB; Okomo U; Alexander ND; Aziz N; Owens BM; Kaur H; Jasseh M; Muangnoicharoen S; Sumariwalla PF; Warhurst DC; Ward SA; Conway DJ; Ulloa L; Tracey KJ; Foxwell BM; Kaye PM; Walther M
PLoS One; 2010 Apr; 5(4):e9867. PubMed ID: 20419161
[TBL] [Abstract][Full Text] [Related]
2. Oral artesunate prevents Plasmodium berghei Anka infection in mice.
Gumede B; Folb P; Ryffel B
Parasitol Int; 2003 Mar; 52(1):53-9. PubMed ID: 12543147
[TBL] [Abstract][Full Text] [Related]
3. Slow and continuous delivery of a low dose of nimodipine improves survival and electrocardiogram parameters in rescue therapy of mice with experimental cerebral malaria.
Martins YC; Clemmer L; Orjuela-Sánchez P; Zanini GM; Ong PK; Frangos JA; Carvalho LJ
Malar J; 2013 Apr; 12():138. PubMed ID: 23617605
[TBL] [Abstract][Full Text] [Related]
4. Further evidence for an anti-inflammatory role of artesunate in experimental cerebral malaria.
Miranda AS; Brant F; Rocha NP; Cisalpino D; Rodrigues DH; Souza DG; Machado FS; Rachid MA; Teixeira AL; Campos AC
Malar J; 2013 Nov; 12():388. PubMed ID: 24180288
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of intranasal administration of artesunate in experimental cerebral malaria.
Marijon A; Bonnot G; Fourier A; Bringer C; Lavoignat A; Gagnieu MC; Bienvenu AL; Picot S
Malar J; 2014 Dec; 13():501. PubMed ID: 25516091
[TBL] [Abstract][Full Text] [Related]
6. S1P is associated with protection in human and experimental cerebral malaria.
Finney CA; Hawkes CA; Kain DC; Dhabangi A; Musoke C; Cserti-Gazdewich C; Oravecz T; Liles WC; Kain KC
Mol Med; 2011; 17(7-8):717-25. PubMed ID: 21556483
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety evaluation of a novel trioxaquine in the management of cerebral malaria in a mouse model.
Odhiambo OC; Wamakima HN; Magoma GN; Kirira PG; Malala BJ; Kimani FT; Muregi FW
Malar J; 2017 Jul; 16(1):268. PubMed ID: 28673299
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of artesunate combined with Atractylodes lancea or Prabchompoothaweep remedy extracts as adjunctive therapy for the treatment of cerebral malaria.
Plirat W; Chaniad P; Phuwajaroanpong A; Konyanee A; Viriyavejakul P; Septama AW; Punsawad C
BMC Complement Med Ther; 2023 Sep; 23(1):332. PubMed ID: 37730604
[TBL] [Abstract][Full Text] [Related]
9. Artesunate and erythropoietin synergistically improve the outcome of experimental cerebral malaria.
Du Y; Chen G; Zhang X; Yu C; Cao Y; Cui L
Int Immunopharmacol; 2017 Jul; 48():219-230. PubMed ID: 28531845
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of proveblue (methylene blue) in an experimental cerebral malaria murine model.
Dormoi J; Briolant S; Desgrouas C; Pradines B
Antimicrob Agents Chemother; 2013 Jul; 57(7):3412-4. PubMed ID: 23612202
[TBL] [Abstract][Full Text] [Related]
11. [Protective effects of artesunate combination on experimental cerebral malaria and nerve injury].
Jiang XH; Chen LN; Li K; Guo Y; Zheng ZY; Yang T; Zheng XJ; Li YJ; Zhu XX
Zhongguo Zhong Yao Za Zhi; 2018 Aug; 43(15):3051-3057. PubMed ID: 30200698
[TBL] [Abstract][Full Text] [Related]
12. Artemether and artesunate show the highest efficacies in rescuing mice with late-stage cerebral malaria and rapidly decrease leukocyte accumulation in the brain.
Clemmer L; Martins YC; Zanini GM; Frangos JA; Carvalho LJ
Antimicrob Agents Chemother; 2011 Apr; 55(4):1383-90. PubMed ID: 21220531
[TBL] [Abstract][Full Text] [Related]
13. Cysteamine broadly improves the anti-plasmodial activity of artemisinins against murine blood stage and cerebral malaria.
Moradin N; Torre S; Gauthier S; Tam M; Hawari J; Vandercruyssen K; De Spiegeleer B; Fortin A; Stevenson MM; Gros P
Malar J; 2016 May; 15(1):260. PubMed ID: 27150250
[TBL] [Abstract][Full Text] [Related]
14. Coenzyme Q10 exhibits anti-inflammatory and immune-modulatory thereby decelerating the occurrence of experimental cerebral malaria.
Nyariki JN; Kimani NM; Kibet PS; Kinuthia GK; Isaac AO
Mol Biochem Parasitol; 2023 Sep; 255():111579. PubMed ID: 37385350
[TBL] [Abstract][Full Text] [Related]
15. Oral Therapy Using a Combination of Nanotized Antimalarials and Immunomodulatory Molecules Reduces Inflammation and Prevents Parasite Induced Pathology in the Brain and Spleen of
Mukherjee S; Ray G; Saha B; Kar SK
Front Immunol; 2021; 12():819469. PubMed ID: 35095923
[TBL] [Abstract][Full Text] [Related]
16. Artesunate-erythropoietin combination for murine cerebral malaria treatment.
Bienvenu AL; Ferrandiz J; Kaiser K; Latour C; Picot S
Acta Trop; 2008 May; 106(2):104-8. PubMed ID: 18359468
[TBL] [Abstract][Full Text] [Related]
17. A comparative clinical trial of sequential treatments of severe malaria with artesunate suppository followed by mefloquine in Thailand.
Looareesuwan S; Wilairatana P; Molunto W; Chalermrut K; Olliaro P; Andrial M
Am J Trop Med Hyg; 1997 Sep; 57(3):348-53. PubMed ID: 9311648
[TBL] [Abstract][Full Text] [Related]
18. Transdermal glyceryl trinitrate as an effective adjunctive treatment with artemether for late-stage experimental cerebral malaria.
Orjuela-Sánchez P; Ong PK; Zanini GM; Melchior B; Martins YC; Meays D; Frangos JA; Carvalho LJ
Antimicrob Agents Chemother; 2013 Nov; 57(11):5462-71. PubMed ID: 23979751
[TBL] [Abstract][Full Text] [Related]
19. Transdermal delivery of artemisinins for treatment of pre-clinical cerebral malaria.
Zech J; Dzikowski R; Simantov K; Golenser J; Mäder K
Int J Parasitol Drugs Drug Resist; 2021 Aug; 16():148-154. PubMed ID: 34116478
[TBL] [Abstract][Full Text] [Related]
20. Reversal of cerebrovascular constriction in experimental cerebral malaria by L-arginine.
Ong PK; Moreira AS; Daniel-Ribeiro CT; Frangos JA; Carvalho LJM
Sci Rep; 2018 Oct; 8(1):15957. PubMed ID: 30374028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
